Dr. Inna Starskaia received a three-year training award from Breakthrough T1D
Dr. Inna Starskaia has been awarded a prestigious three-year training award from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.
The funded project, titled “In-depth analysis of immune response to identify changes associated with progression and endotypes of type 1 diabetes”, will apply state-of-the-art genomics, deep immune profiling, and advanced computational tools to study changes of immune response and correlate them with clinical measurements to better understand the different pathogenic mechanisms underlying type 1 diabetes and open the possibility for prediction and prevention of the disease. The research aims to identify novel biomarkers and disease stratifiers associated with disease progression, potentially contributing to the development of more effective and personalized therapeutic strategies.
The study will be carried out in Professor Riitta Lahesmaa’s research group at the Turku Bioscience Centre, University of Turku. The group belongs to the InFLAMES Research Flagship Center.
This award recognizes the high potential and impact of the proposed research and will significantly contribute to advancements in the field of type 1 diabetes research.
Recent Posts
-
Season’s Greetings & Happy 2026!
Season’s Greetings & Happy 2026! From everyone at Turku Bioscience. Riitta Lahesmaa,Director of Turku Bioscience Read moreDecember 23, 2025
-
The Sigrid Jusélius senior researcher posts grant to Carlos Rogerio Figueiredo
The Sigrid Jusélius Foundation has awarded a four-year senior researcher grant of €700,000 to our Read moreDecember 15, 2025
-
Guillaume Jacquemet awarded the 2025 Chancellor’s Prize
Guillaume Jacquemet, a Group Leader at our centre, has been awarded the Chancellor’s Prize for Read moreDecember 15, 2025
-
New Funding for our Centre’s Researchers
Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025
-
Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work.
Medical association Duodecim selects each year persons that have been most influential in the field Read moreDecember 11, 2025
-
Our affiliated Group Leader Rafa Najumudeen secures ERC Consolidator Grant
The European Research Council (ERC) has awarded a Consolidator Grant to our affiliated Group Leader, Read moreDecember 9, 2025